{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Aidi injection", "Doxorubicin", "Doxorubicinol", "Hepatocellular carcinoma", "Pharmacokinetic herb-drug interaction", "Rat"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34488896", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "27"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "09", "Day": "06"}], "Language": ["eng"], "ELocationID": ["48", "10.1186/s40360-021-00515-9"], "Journal": {"ISSN": "2050-6511", "JournalIssue": {"Volume": "22", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Sep", "Day": "06"}}, "Title": "BMC pharmacology & toxicology", "ISOAbbreviation": "BMC Pharmacol Toxicol"}, "ArticleTitle": "Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma.", "Pagination": {"StartPage": "48", "MedlinePgn": "48"}, "Abstract": {"AbstractText": ["Aidi Injection (ADI), a Chinese herbal preparation with anti-cancer activity, is used for the treatment of hepatocellular carcinoma (HCC). Several clinical studies have shown that co-administration of ADI with doxorubicin (DOX) is associated with reduced toxicity of chemotherapy, enhanced clinical efficacy and improved quality of life for patients. However, limited information is available about the herb-drug interactions between ADI and DOX. The study aimed to investigate the pharmacokinetic mechanism of herb-drug interactions between ADI and DOX in a rat model of HCC.", "Experimental HCC was induced in rats by oral administration of diethylnitrosamine. The HCC rats were pretreated with ADI (10\u2009mL/kg, intraperitoneal injection) for 14 consecutive days prior to administration of DOX (7\u2009mg/kg, intravenous injection) to investigate pharmacokinetic interactions. Plasma concentrations of DOX and its major metabolite, doxorubicinol (DOXol), were determined using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).", "Preadministration of ADI significantly altered the pharmacokinetics of DOX in HCC rats, leading to increased plasma concentrations of both DOX and DOXol. The area under the plasma drug concentration-time curve (AUCs) of DOX and DOXol in rats pretreated with ADI were 3.79-fold and 2.92-fold higher, respectively, than those in control rats that did not receive ADI.", "Increased levels of DOX and DOXol were found in the plasma of HCC rats pretreated with ADI."], "CopyrightInformation": "\u00a9 2021. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, No.9, Beijing Road, Yunyan District, Guiyang, 550004, China."}], "LastName": "Lu", "ForeName": "Yuan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, No.9, Beijing Road, Yunyan District, Guiyang, 550004, China."}, {"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, 550004, China."}], "LastName": "Pan", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, No.9, Beijing Road, Yunyan District, Guiyang, 550004, China."}], "LastName": "Zhu", "ForeName": "Xiaoqing", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Interventional Radiology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, 550000, China."}], "LastName": "Zhang", "ForeName": "Shuai", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, No.9, Beijing Road, Yunyan District, Guiyang, 550004, China."}, {"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, 550004, China."}], "LastName": "Liu", "ForeName": "Chunhua", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, No.9, Beijing Road, Yunyan District, Guiyang, 550004, China."}], "LastName": "Sun", "ForeName": "Jia", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, No.9, Beijing Road, Yunyan District, Guiyang, 550004, China."}, {"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, 550004, China."}], "LastName": "Li", "ForeName": "Yueting", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, No.9, Beijing Road, Yunyan District, Guiyang, 550004, China."}], "LastName": "Chen", "ForeName": "Siying", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, No.9, Beijing Road, Yunyan District, Guiyang, 550004, China."}], "LastName": "Huang", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, No.9, Beijing Road, Yunyan District, Guiyang, 550004, China."}], "LastName": "Cao", "ForeName": "Chuang", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, No.9, Beijing Road, Yunyan District, Guiyang, 550004, China."}], "LastName": "Wang", "ForeName": "Yonglin", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, No.9, Beijing Road, Yunyan District, Guiyang, 550004, China. 1838174671@qq.com."}, {"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, 550004, China. 1838174671@qq.com."}], "LastName": "Li", "ForeName": "Yongjun", "Initials": "Y"}, {"Identifier": ["0000-0002-5824-3975"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, 550004, China. t-liu@163.com."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, No.9, Beijing Road, Yunyan District, Guiyang, 550004, China. t-liu@163.com."}], "LastName": "Liu", "ForeName": "Ting", "Initials": "T"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Pharmacol Toxicol", "NlmUniqueID": "101590449", "ISSNLinking": "2050-6511"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antibiotics, Antineoplastic"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "aidi herbal drug"}, {"RegistryNumber": "3IQ78TTX1A", "NameOfSubstance": "Diethylnitrosamine"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["blood", "pharmacokinetics"], "DescriptorName": "Antibiotics, Antineoplastic"}, {"QualifierName": [], "DescriptorName": "Area Under Curve"}, {"QualifierName": ["blood", "chemically induced", "metabolism"], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": [], "DescriptorName": "Diethylnitrosamine"}, {"QualifierName": ["blood", "pharmacokinetics"], "DescriptorName": "Doxorubicin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Herb-Drug Interactions"}, {"QualifierName": ["blood", "chemically induced", "metabolism"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": [], "DescriptorName": "Rats"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317\u2013370. doi: 10.1007/s12072-017-9799-9.", "ArticleIdList": ["10.1007/s12072-017-9799-9", "PMC5491694", "28620797"]}, {"Citation": "Cox J, Weinman S. Mechanisms of doxorubicin resistance in hepatocellular carcinoma. Hepat Oncol. 2016;3(1):57\u201359. doi: 10.2217/hep.15.41.", "ArticleIdList": ["10.2217/hep.15.41", "PMC4792121", "26998221"]}, {"Citation": "Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, Altman RB. Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics. 2011;21(7):440\u2013446. doi: 10.1097/FPC.0b013e32833ffb56.", "ArticleIdList": ["10.1097/FPC.0b013e32833ffb56", "PMC3116111", "21048526"]}, {"Citation": "Hamza AA, Ahmed MM, Elwey HM, Amin A. Melissa officinalis protects against doxorubicin-induced cardiotoxicity in rats and potentiates its anticancer activity on MCF-7 cells. PLoS One. 2016;11(11):e0167049. doi: 10.1371/journal.pone.0167049.", "ArticleIdList": ["10.1371/journal.pone.0167049", "PMC5120835", "27880817"]}, {"Citation": "Amin A, Mahmoud-Ghoneim D, Syam MI, Daoud S. Neural network assessment of herbal protection against chemotherapeutic-induced reproductive toxicity. Theor Biol Med Model. 2012;9(1):1. doi: 10.1186/1742-4682-9-1.", "ArticleIdList": ["10.1186/1742-4682-9-1", "PMC3293062", "22272939"]}, {"Citation": "Korga A, Ostrowska M, Jozefczyk A, Iwan M, Wojcik R, Zgorka G, Herbet M, Vilarrubla GG, Dudka J. Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells. BMC Pharmacol Toxicol. 2019;20(1):22. doi: 10.1186/s40360-019-0301-2.", "ArticleIdList": ["10.1186/s40360-019-0301-2", "PMC6499973", "31053173"]}, {"Citation": "Xiao Z, Wang C, Li L, Tang X, Li N, Li J, Chen L, Gong Q, Tang F, Feng J, Li X. Clinical efficacy and safety of Aidi injection plus docetaxel-based chemotherapy in advanced nonsmall cell lung Cancer: a Meta-analysis of 36 randomized controlled trials. Evid Based Complement Alternat Med. 2018;2018:7918258.", "ArticleIdList": ["PMC6016159", "29991956"]}, {"Citation": "Xie G, Cui Z, Peng K, Zhou X, Xia Q, Xu D. Aidi injection, a traditional Chinese medicine injection, Could Be Used as an Adjuvant Drug to Improve Quality of Life of Cancer Patients Receiving Chemotherapy: A Propensity Score Matching Analysis Integr Cancer Ther. 2019;18:1534735418810799.", "ArticleIdList": ["PMC6432675", "30482065"]}, {"Citation": "Xiao Z, Wang C, Zhou M, Hu S, Jiang Y, Huang X, Li N, Feng J, Tang F, Chen X, Ding J, Chen L, Wang Y, Li X. Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: a meta-analysis of 31 randomized controlled trials following the PRISMA guidelines. J Ethnopharmacol. 2019;228:110\u2013122. doi: 10.1016/j.jep.2018.09.024.", "ArticleIdList": ["10.1016/j.jep.2018.09.024", "30243827"]}, {"Citation": "Liu D, Chen Z. The effects of cantharidin and cantharidin derivates on tumour cells. Anti Cancer Agents Med Chem. 2009;9(4):392\u2013396. doi: 10.2174/1871520610909040392.", "ArticleIdList": ["10.2174/1871520610909040392", "19442040"]}, {"Citation": "Han W, Wang S, Liang R, Wang L, Chen M, Li H, Wang Y. Non-ionic surfactant vesicles simultaneously enhance antitumor activity and reduce the toxicity of cantharidin. Int J Nanomedicine. 2013;8:2187\u20132196. doi: 10.2147/IJN.S43568.", "ArticleIdList": ["10.2147/IJN.S43568", "PMC3686241", "23807847"]}, {"Citation": "Kim JA, Kim Y, Kwon BM, Han DC. The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70) and Bcl-2-associated athanogene domain 3 (BAG3) expression by blocking heat shock factor 1 (HSF1) binding to promoters. J Biol Chem. 2013;288(40):28713\u201328726. doi: 10.1074/jbc.M113.488346.", "ArticleIdList": ["10.1074/jbc.M113.488346", "PMC3789968", "23983126"]}, {"Citation": "Zhang W, Ma YZ, Song L, Wang CH, Qi TG, Shao GR. Effect of cantharidins in chemotherapy for hepatoma: a retrospective cohort study. Am J Chin Med. 2014;42(3):561\u2013567. doi: 10.1142/S0192415X14500360.", "ArticleIdList": ["10.1142/S0192415X14500360", "24871651"]}, {"Citation": "Zhang YM, Liu YQ, Liu D, Zhang L, Qin J, Zhang Z, Su Y, Yan C, Luo YL, Li J, Xie X, Guan Q. The effects of Astragalus polysaccharide on bone marrow-derived mesenchymal stem cell proliferation and morphology induced by A549 lung Cancer cells. Med Sci Monit. 2019;25:4110\u20134121. doi: 10.12659/MSM.914219.", "ArticleIdList": ["10.12659/MSM.914219", "PMC6561146", "31154455"]}, {"Citation": "Zheng Y, Ren W, Zhang L, Zhang Y, Liu D, Liu Y. A review of the pharmacological action of Astragalus polysaccharide. Front Pharmacol. 2020;11:349. doi: 10.3389/fphar.2020.00349.", "ArticleIdList": ["10.3389/fphar.2020.00349", "PMC7105737", "32265719"]}, {"Citation": "Kondeva-Burdina M, Shkondrov A, Simeonova R, Vitcheva V, Krasteva I, Ionkova I. In vitro/in vivo antioxidant and hepatoprotective potential of defatted extract and flavonoids isolated from Astragalus spruneri Boiss. (Fabaceae). Food Chem. Toxicol. 2018;111:631\u201340.", "ArticleIdList": ["29247771"]}, {"Citation": "Li LK, Kuang WJ, Huang YF, Xie HH, Chen G, Zhou QC, Wang BR, Wan LH. Anti-tumor effects of Astragalus on hepatocellular carcinoma in vivo. Indian J Pharmacol. 2012;44(1):78\u201381. doi: 10.4103/0253-7613.91872.", "ArticleIdList": ["10.4103/0253-7613.91872", "PMC3271545", "22345875"]}, {"Citation": "Yoon TJ, Yoo YC, Lee SW, Shin KS, Choi WH, Hwang SH, Ha ES, Jo SK, Kim SH, Park WM. Anti-metastatic activity of Acanthopanax senticosus extract and its possible immunological mechanism of action. J Ethnopharmacol. 2004;93(2\u20133):247\u2013253. doi: 10.1016/j.jep.2004.03.052.", "ArticleIdList": ["10.1016/j.jep.2004.03.052", "15234760"]}, {"Citation": "Yang X, Zou J, Cai H, Huang X, Yang X, Guo D, Cao Y. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBP\u03b2/NF-\u03baB signaling. Biomed Pharmacother. 2017;96:1240\u20131245. doi: 10.1016/j.biopha.2017.11.092.", "ArticleIdList": ["10.1016/j.biopha.2017.11.092", "29169725"]}, {"Citation": "Dai G, Sun B, Gong T, Pan Z, Meng Q, Ju W. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-\u03b2/Smad signaling. Phytomedicine. 2019;56:126\u2013135. doi: 10.1016/j.phymed.2018.10.025.", "ArticleIdList": ["10.1016/j.phymed.2018.10.025", "30668333"]}, {"Citation": "Xiao Z, Jiang Y, Chen XF, Wang CQ, Xu WH, Liu Y, et. al. The Hepatorenal Toxicity and Tumor Response of Chemotherapy With or Without Aidi Injection in Advanced Lung Cancer: A Meta-Analysis of 80 Randomized Controlled Trials. Clin Ther. 2020;42(3):515\u201343.e31.", "ArticleIdList": ["32088021"]}, {"Citation": "Xiao Z, Liang R, Wang CQ, Xu S, Li N, He Y, Tang F, Chen L, Ma H. Can Aidi injection alleviate the toxicity and improve the clinical efficacy of radiotherapy in lung cancer?: a meta-analysis of 16 randomized controlled trials following the PRISMA guidelines. Medicine (Baltimore) 2016;95(35):e4517. doi: 10.1097/MD.0000000000004517.", "ArticleIdList": ["10.1097/MD.0000000000004517", "PMC5008545", "27583861"]}, {"Citation": "Fan J, de Lannoy IA. Pharmacokinetics. Biochem Pharmacol. 2014;87(1):93\u2013120. doi: 10.1016/j.bcp.2013.09.007.", "ArticleIdList": ["10.1016/j.bcp.2013.09.007", "24055064"]}, {"Citation": "Lu Y, Pan J, Yang ST, Wu Q, Liu CH, Li YJ, Liu T. Effect of Aidi injection on glutathione-S-transferase of diethynitrosamine-induced hepatocellular carcinoma model rats. Chin Pharma Bull. 2018;34(8):1170\u20131174."}, {"Citation": "Pan J, Lu Y, Zhang S, Li YT, Sun J, Liu CH, Gong ZP, Huang J, Cao C, Wang YL, Li YJ, Liu T. Differential changes in the pharmacokinetics of doxorubicin in diethylnitrosamine-induced hepatocarcinoma model rats. Xenobiotica. 2020;50(10):1251\u20131257. doi: 10.1080/00498254.2020.1765049.", "ArticleIdList": ["10.1080/00498254.2020.1765049", "32375563"]}, {"Citation": "Lu Y, Pan J, Yang ST, Liu CH, Li YJ, Liu T. Effect of Aidi injection on in vivo pharmacokinetics of doxorubicin in Sprague-Dawley rats by UPLC-MS method. Chin. Pharma. Bull. 2018;34(3):423\u2013427."}, {"Citation": "Gomes AS, Monteleone PA, Sayre JW, Finn RS, Sadeghi S, Tong MJ, Britten CD, Busuttil RW. Comparison of triple-drug transcatheter arterial chemoembolization (TACE) with single-drug TACE using doxorubicin-eluting beads: long-term survival in 313 patients. AJR Am J Roentgenol. 2017;209(4):722\u2013732. doi: 10.2214/AJR.17.18219.", "ArticleIdList": ["10.2214/AJR.17.18219", "28705059"]}, {"Citation": "Sun JH, Zhou GH, Zhang YL, Nie CH, Zhou TY, Ai J, Zhu TY, Wang WL, Zheng SS. Chemoembolization of liver cancer with drug-loading microsphere 50\u2013100 \u03bcm. Oncotarget. 2017;8(3):5392\u20135399. doi: 10.18632/oncotarget.14281.", "ArticleIdList": ["10.18632/oncotarget.14281", "PMC5354917", "28036272"]}, {"Citation": "Cao W, Li J, Hu C, Shen J, Liu X, Xu Y, Ye Z. Symptom clusters and symptom interference of HCC patients undergoing TACE: a cross-sectional study in China. Support Care Cancer. 2013;21(2):475\u2013483. doi: 10.1007/s00520-012-1541-5.", "ArticleIdList": ["10.1007/s00520-012-1541-5", "23010958"]}, {"Citation": "Wan YM, Li YH, Xu ZY, Wu HM, Xu Y, Yang M, Wu XN. The effect of Transarterial chemoembolization in combination with Kang'ai injection on patients with intermediate stage hepatocellular carcinoma: a prospective study. Integr Cancer Ther. 2018;17(2):477\u2013485. doi: 10.1177/1534735417734913.", "ArticleIdList": ["10.1177/1534735417734913", "PMC6041935", "29108428"]}, {"Citation": "Hu B, Wang SS, Du Q. Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: from bench to bedside. World J Hepatol. 2015;7(9):1209\u20131232. doi: 10.4254/wjh.v7.i9.1209.", "ArticleIdList": ["10.4254/wjh.v7.i9.1209", "PMC4438495", "26019736"]}, {"Citation": "Dai Y, Gao S, Liu X, Gao Q, Zhang L, Fan X, et al. Effect of Aidi injection plus TACE on hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2018;9196409.", "ArticleIdList": ["PMC6311847", "30647765"]}, {"Citation": "Sun XF, Pei YT, Yin QW, Wu MS, Yang GT. Application of Aidi injection (\u827e\u8fea\u6ce8\u5c04\u6db2) in the bronchial artery infused neo-adjuvant chemotherapy for stage III a non-small cell lung cancer before surgical operation. Chin J Integr Med. 2010;16(6):537\u2013541. doi: 10.1007/s11655-010-0569-y.", "ArticleIdList": ["10.1007/s11655-010-0569-y", "21110180"]}, {"Citation": "Wu L, Tang ZY, Li Y. Experimental models of hepatocellular carcinoma: developments and evolution. J Cancer Res Clin Oncol. 2009;135(8):969\u2013981. doi: 10.1007/s00432-009-0591-7.", "ArticleIdList": ["10.1007/s00432-009-0591-7", "19399516"]}, {"Citation": "Santos NP, Cola\u00e7o AA, Oliveira PA. Animal models as a tool in hepatocellular carcinoma research: a review. Tumour Biol. 2017;39(3):1010428317695923. doi: 10.1177/1010428317695923.", "ArticleIdList": ["10.1177/1010428317695923", "28347231"]}, {"Citation": "Lal S, Mahajan A, Chen WN, Chowbay B. Pharmacogenetics of target genes across doxorubicin disposition pathway: a review. Curr Drug Metab. 2010;11(1):115\u2013128. doi: 10.2174/138920010791110890.", "ArticleIdList": ["10.2174/138920010791110890", "20302569"]}, {"Citation": "Bains OS, Karkling MJ, Grigliatti TA, Reid RE, Riggs KW. Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin. Drug Metab Dispos. 2009;37(5):1107\u20131114. doi: 10.1124/dmd.108.024711.", "ArticleIdList": ["10.1124/dmd.108.024711", "19204081"]}, {"Citation": "Chen T, Wang C, Liu Q, Meng Q, Sun H, Huo X, Sun P, Peng J, Liu Z, Yang X, Liu K. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway. Cancer Biol Ther. 2015;16(1):106\u2013114. doi: 10.4161/15384047.2014.987062.", "ArticleIdList": ["10.4161/15384047.2014.987062", "PMC4622436", "25482933"]}, {"Citation": "Zhao YY, Yu L, Liu BL, He XJ, Zhang BY. Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines. Mol Med Rep. 2015;12(5):7335\u20137343. doi: 10.3892/mmr.2015.4367.", "ArticleIdList": ["10.3892/mmr.2015.4367", "PMC4626124", "26459009"]}, {"Citation": "Nanayakkara AK, Follit CA, Chen G, Williams NS, Vogel PD, Wise JG. Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells. Sci Rep. 2018;8(1):967. doi: 10.1038/s41598-018-19325-x.", "ArticleIdList": ["10.1038/s41598-018-19325-x", "PMC5772368", "29343829"]}, {"Citation": "Lal S, Wong ZW, Jada SR, Xiang X, Chen Shu X, Ang PC, Figg WD, Lee EJ, Chowbay B. Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients. Pharmacogenomics. 2007;8(6):567\u2013575. doi: 10.2217/14622416.8.6.567.", "ArticleIdList": ["10.2217/14622416.8.6.567", "17559346"]}, {"Citation": "Dong SC, Sha HH, Xu XY, Hu TM, Lou R, Li H, Wu JZ, Dan C, Feng J. Glutathione S-transferase \u03c0: a potential role in antitumor therapy. Drug Des Devel Ther. 2018;12:3535\u20133547. doi: 10.2147/DDDT.S169833.", "ArticleIdList": ["10.2147/DDDT.S169833", "PMC6204874", "30425455"]}, {"Citation": "Pljesa-Ercegovac M, Savic-Radojevic A, Matic M, Coric V, Djukic T, Radic T, Simic T. Glutathione transferases: potential targets to overcome chemoresistance in solid tumors. Int J Mol Sci. 2018;19(12):3785. doi: 10.3390/ijms19123785.", "ArticleIdList": ["10.3390/ijms19123785", "PMC6321424", "30487385"]}, {"Citation": "Zhu C, Wang Y, Liu H, Mu H, Lu Y, Zhang J, Huang J. Oral administration of Ginsenoside Rg1 prevents cardiac toxicity induced by doxorubicin in mice through anti-apoptosis. Oncotarget. 2017;8(48):83792\u201383801. doi: 10.18632/oncotarget.19698.", "ArticleIdList": ["10.18632/oncotarget.19698", "PMC5663555", "29137383"]}, {"Citation": "Wang X, Chen L, Wang T, Jiang X, Zhang H, Li P, Lv B, Gao X. Ginsenoside Rg3 antagonizes adriamycin-induced cardiotoxicity by improving endothelial dysfunction from oxidative stress via upregulating the Nrf2-ARE pathway through the activation of akt. Phytomedicine. 2015;22(10):875\u2013884. doi: 10.1016/j.phymed.2015.06.010.", "ArticleIdList": ["10.1016/j.phymed.2015.06.010", "26321736"]}, {"Citation": "Zhou B, Yan Z, Liu R, Shi P, Qian S, Qu X, Zhu L, Zhang W, Wang J. Prospective study of transcatheter arterial chemoembolization (TACE) with ginsenoside Rg3 versus TACE alone for the treatment of patients with advanced hepatocellular carcinoma. Radiology. 2016;280(2):630\u2013639. doi: 10.1148/radiol.2016150719.", "ArticleIdList": ["10.1148/radiol.2016150719", "26885681"]}, {"Citation": "Li L, Ni J, Li M, Chen J, Han L, Zhu Y, Kong D, Mao J, Wang Y, Zhang B, Zhu M, Gao X, Fan G. Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy. Drug Delivery. 2017;24(1):1617\u20131630. doi: 10.1080/10717544.2017.1391893.", "ArticleIdList": ["10.1080/10717544.2017.1391893", "PMC8241051", "29063791"]}, {"Citation": "Cao Y, Ruan Y, Shen T, Huang X, Li M, Yu W, Zhu Y, Man Y, Wang S, Li J. Astragalus polysaccharide suppresses doxorubicin-induced cardiotoxicity by regulating the PI3k/Akt and p38MAPK pathways. Oxidative Med Cell Longev. 2014;2014:674219. doi: 10.1155/2014/674219.", "ArticleIdList": ["10.1155/2014/674219", "PMC4216718", "25386226"]}, {"Citation": "Cao Y, Shen T, Huang X, Lin Y, Chen B, Pang J, Li G, Wang Q, Zohrabian S, Duan C, Ruan Y, Man Y, Wang S, Li J. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity. Oncotarget. 2017;8(3):4837\u20134848. doi: 10.18632/oncotarget.13596.", "ArticleIdList": ["10.18632/oncotarget.13596", "PMC5341749", "27902477"]}, {"Citation": "Liang Q, Yu X, Qu S, Xu H, Sui D. Acanthopanax senticosides B ameliorates oxidative damage induced by hydrogen peroxide in cultured neonatal rat cardiomyocytes. Eur J Pharmacol. 2010;627(1):209\u2013215. doi: 10.1016/j.ejphar.2009.10.055.", "ArticleIdList": ["10.1016/j.ejphar.2009.10.055", "19879870"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "5", "Day": "13"}, {"Year": "2021", "Month": "8", "Day": "10"}, {"Year": "2021", "Month": "9", "Day": "7", "Hour": "6", "Minute": "4"}, {"Year": "2021", "Month": "9", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["34488896", "PMC8419969", "10.1186/s40360-021-00515-9", "10.1186/s40360-021-00515-9"]}}], "PubmedBookArticle": []}